Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exogen (US) prepares for European launch of sonic fracture healing

This article was originally published in Clinica

Executive Summary

Exogen (US) is gearing up for the European launch of its sonic accelerated fracture healing process scheduled for the beginning of next year. The company has set up a European subsidiary in Diessen, near Munich, in Germany and has completed distribution agreements in Italy, France, the Netherlands and the UK. The Exogen system received US FDA clearance last year and has gained favourable assessments for reimbursement from Blue Cross/Blue Shield (see Clinica No 668, p 20).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel